Work

Abstract 2137: EVOLVE205, a dual (2:1) CD20 targeted CD3 trispecific T cell engager with CD2 costimulation for the treatment of B cell malignancies and B cell autoimmune disorders

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-2137

Authors: Xingyue An, Mohosin Sarkar, Guixian Jin, Tiffany Liang, Afsana Sabrin, Tracy Lichter, Danielle Klaskin, Evelyn Teran, Abliz Abduqadir, Hayden Karp, Julio Rodriguez, Hemachander Capiralla, Zengzu Lai, Louis Matis, Stella Martomo, Agnes Meade, Martin Preyer, Jay S. Fine, Jeremy S. Myers

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409628809

Cites:

Cited by: 1

Related to: 10